초록 ▼

Apparatus and method for separation of milk and milk products, e.g., involving sequential separation of milk, clostrum, and whey components by cross-flow filtration. The apparatus and method in a preferred aspect employ cross-flow filtration, chromatography and fermentation to separate and fully uti

Apparatus and method for separation of milk and milk products, e.g., involving sequential separation of milk, clostrum, and whey components by cross-flow filtration. The apparatus and method in a preferred aspect employ cross-flow filtration, chromatography and fermentation to separate and fully utilize the components of milk, clostrum, and whey to generate numerous individual components, minimize waste, lower adverse environmental issues and provide enhanced economic benefits to dairy producers. A wide variety of consumer and nutraceutical products can be produced from the fractions and/or sub-fractions of milk products obtained from such separation. The invention further contemplates a methodology for selecting optimum membrane, device, and operating conditions to achieve a desired separation.

대표청구항 ▼

1. A method for sequentially separating components of milk, comprising the steps of:(a) providing a milk source; (b) effectuating a sufficient flow of milk from the milk source through one or more cross-flow filtration modules, using one or more fluid delivery means, wherein each fluid delivery mean

1. A method for sequentially separating components of milk, comprising the steps of:(a) providing a milk source; (b) effectuating a sufficient flow of milk from the milk source through one or more cross-flow filtration modules, using one or more fluid delivery means, wherein each fluid delivery means is connected to at least one cross-flow filtration module; and (c) sequentially capturing one or more filtration fractions generated by the cross-flow filtration modules, wherein the milk is physically separated by said one or more cross-flow filtration modules into milk components, and wherein said physical separation of milk components is based on their different molecular weights and/or operating conditions. 2. A method according to claim 1, wherein each cross-flow filtration module comprises at least one permeate, at least one inlet, at least one outlet, and multiple fluid-flow sub-channels each extending between the inlet and outlet, that are of equal length to one another as measured between the inlet and the outlet.3. A method according to claim 1, wherein the cross-flow filtration modules comprise filtration membranes selected from the group consisting of cellulose-based membranes, polymer-based membranes, and ceramic-based membranes.4. A method according to claim 1, wherein the milk from the milk source is flown through a cream separator upstream of the cross-flow filtration modules to remove at least part of a fatty component of the milk.5. A method according to claim 1, wherein the milk is pasteurized before being flowed to the cross-flow filtration modules.6. A method according to claim 1, further comprising the step of controlling and monitoring temperature of the fluid within the cross-flow filtration modules.7. A method according to claim 1, further comprising the step of recycling water generated by the cross-flow filtration modules.8. A method according to claim 1, wherein the milk is flowed through a cross-flow filtration module to be separated into a casein-rich fraction and a casein-depleted fraction.9. A method according to claim 8, wherein the casein-rich fraction of the milk is captured as retentate of the cross-flow filtration module, and wherein the casein-depleted fraction of the milk is captured as permeate of the cross-flow filtration module.10. A method according to claim 8, wherein the cross-flow filtration module comprises a cellulose-based membrane selected from the group consisting of cellulose membranes, cellulose acetate membranes, and regenerated cellulose membranes.11. A method according to claim 8, wherein the cross-flow filtration module comprises a membrane having an average pore size in a range of from about 100 KD to about 3000 KD.12. A method according to claim 8, wherein the cross-flow filtration module comprises a membrane having an average pore size in a range of from about 100 KD to about 1000 KD.13. A method according to claim 8, wherein the cross-flow filtration module comprises a membrane having an average pore size in a range of from about 100 KD to about 500 KD.14. A method according to claim 8, wherein the cross-flow filtration module comprises a regenerated cellulose membrane having an average pore size of about 100 KD.15. A method according to claim 8, further comprising the step of concentrating and/or diafiltering the casein-rich fraction.16. A method according to claim 8, further comprising the step of concentrating and/or diafiltering the casein-depleted fraction.17. A method according to claim 8, wherein the casein-rich fraction is used to manufacture a dairy product selected from the group consisting of: cheese, milk powder, and substrate for milk protein concentrate.18. A method according to claim 8, wherein the casein-depleted fraction is used to manufacture a diary product selected from the group consisting of: whey protein isolates, whey protein subcomponents, and whey protein concentrates.19. A method according to claim 8, further comprising the steps of:adding fatty component of milk to the casein-rich fraction; and drying said casein-rich fraction to form milk powder enriched with the fatty component of milk. 20. A method according to claim 1, comprising the steps of:optionally flowing the milk from the milk source through a first cross-flow filtration module to remove at least a portion of bacteria contained therein; flowing the milk, optionally filtered in the first cross-flow filtration module, through a second cross-flow filtration module to separate the milk into a casein-rich fraction and a casein-depleted fraction; capturing the casein-rich fraction; flowing the casein-depleted fraction of the milk through a third cross-flow filtration module to form a fraction that is enriched with albumin and immunoglobulins and a fraction that is depleted of albumin and immunoglobulins; capturing the fraction that is enriched with albumin and immunoglobulins; flowing the fraction that is depleted of albumin and immunoglobulins of the milk through a fourth cross-flow filtration module to form a β-lactoglobulin-rich fraction and a β-lactoglobulin-depleted fraction; capturing the β-lactoglobulin-rich fraction; flowing the β-lactoglobulin-depleted fraction of the milk through a fifth cross-flow filtration module to form a α-lactalbumin-rich fraction and a α-lactalbumin-depleted fraction; capturing the α-lactalbumin-rich fraction; flowing the α-lactalbumin-depleted fraction of the milk through a sixth cross-flow filtration module to form a complex carbohydrates rich fraction and a complex carbohydrates depleted fraction; capturing the complex carbohydrates rich fraction; flowing the complex carbohydrates depleted fraction through a seventh cross-flow filtration module to form a lactose-rich fraction and a lactose-depleted fraction; capturing the lactose-rich fraction; and discharging and/or recyclying the lactose-depleted fraction of milk. 21. A method according to claim 20, further comprising the step of pasteurizing the milk source and/or any fraction of the milk components generated therein.22. A method according to claim 20, wherein the cross-flow filtration modules comprise filtration membranes selected from the group consisting of cellulose-based membranes, polymer-based membranes, and ceramic-based membranes.23. A method according to claim 20, wherein the second cross-flow filtration module comprises a cellulose-based membrane selected from the group consisting of cellulose membranes, cellulose acetate membranes, and regenerated cellulose membranes.24. A method according to claim 20, wherein the second cross-flow filtration module comprises a membrane having average pore size in the range from about 100 KD to about 3000 KD.25. A method according to claim 20, wherein the second cross-flow filtration module comprises a membrane having an average pore size in a range of from about 100 KD to about 1000 KD, selected from the group consisting of cellulose-based membranes selected from the group consisting of cellulose membranes, cellulose acetate membranes, and regenerated cellulose membranes.26. A method according to claim 20, wherein the second cross-flow filtration module comprises a polymeric membrane having an average pore size in a range of between 800 KD and 2500 KD and/or a measured bubble point between 65 and 120 PSIG.27. A method according to claim 20, wherein the second cross-flow filtration module comprises a regenerated cellulose membrane having an average pore size of about 100 KD.28. A method according to claim 20, further comprising the step of separating and purifying albumin and immunoglobulins from the fraction that is enriched with albumin and immunoglobulins, using a method selected from the group consisting of chromatography, cross-flow filtration, cross-flow chromatography, and diafiltration.29. A method according to claim 20, further comprising the step of separating and purifying β-lactoglobulin from the β-lactoglobulin-rich fraction of the milk, using a method selected from the group consisting of chromatography, cross-flow filtration, cross-flow chromatography, and diafiltration.30. A method according to claim 20, further comprising the step of separating and purifying α-lactalbumin from the α-lactalbumin-rich fraction of the milk, using a method selected from the group consisting of chromatography, cross-flow filtration, cross-flow chromatography, and diafiltration.31. A method according to claim 30, further comprising the step of adding the separated and purified α-lactalbumin into the casein-depleted fraction of the milk generated by the second cross-flow filtration module to form an α-lactalbumin-enriched soluble milk protein concentrate.32. A method according to claim 31, further comprising the step of drying the α-lactalbumin-enriched soluble milk protein concentrate to form a powder product.33. A method according to claim 20, further comprising the step of separating and purifying complex carbohydrates from the complex carbohydrates-rich fraction of the milk, using a method selected from the group consisting of chromatography, cross-flow filtration, cross-flow chromatography, and diafiltration.34. A method according to 33, further comprising the step of fractioning the complex carbohydrates into one or more subcomponents using one or more cross-flow filtration modules.35. A method according to claim 20, further comprising the step of subjecting the lactose-rich fraction of the milk to a bacterial process and/or an enzymatic process.36. A method according to claim 20, further comprising the step of fermenting the lactose-rich fraction of the milk to produce at least one product selected from the group consisting of lactobacillus, lactic acid, and Vitamin B-12.37. A method according to claim 20, further comprising the step of crystallizing the lactose-rich fraction of the milk to produce at least one product selected from the group consisting of lactobacillus, lactic acid, and Vitamin B-12.38. A method according to claim 20, further comprising the step of combining the casein-rich fraction from the second cross-flow filtration module with the α-lactalbumin-rich fraction from the fifth cross-flow filtration module to form an α-lactalbumin-enriched substrate for cheese manufacturing.39. A method according to claim 20, further comprising the step of drying at least one of the captured fractions of milk by a method selected from the group consisting of lyophilization, spray-drying, freeze-drying, crystallization, and evaporation.40. A method according to claim 20, wherein each cross-flow filtration module is connected to at least one fluid delivery means for flowing the milk or a fraction of the milk therethrough.41. A method according to claim 20, wherein temperature of each cross-flow filtration module is controlled and monitored by temperature controlling/monitoring means.42. A method according to claim 1, wherein sialyllactose is isolated from the milk, said method comprising the steps of:optionally flowing the milk from the milk source through a first cross-flow filtration module to filter out at least a portion of bacteria contained therein; flowing the milk, optionally filtered in the first cross-flow filtration module, through a second cross-flow filtration module to separate the milk into a casein-rich fraction and a casein-depleted fraction; capturing the casein-rich fraction; flowing the casein-depleted fraction of the milk through a third cross-flow filtration module to form a fraction that is enriched with milk proteins selected from the group consisting of albumin, immunoglobulins, β-lactoglobulin, and α-lactalbumin, and a fraction that is depleted of said milk proteins; capturing the fraction that is enriched with milk proteins selected from the group consisting of albumin, immunoglobulins, β-lactoglobulin, and α-lactalbumin; flowing the fraction that is depleted of said milk proteins through a fourth cross-flow filtration module to form a sialyllactose-enriched fraction and a sialyllactose-depleted fraction; capturing the sialyllactose-enriched fraction; and discharging the sialyllactose-depleted fraction. 43. A method according to claim 1, wherein the milk source supplies casein-depleted whey, and wherein sialyllactose is separated from said casein-depleted whey, comprising the steps of:optionally flowing the casein-depleted whey from the milk source through a first cross-flow filtration module to filter out at least a portion of bacteria contained therein; flowing the casein-depleted whey, optionally filtered in the first cross-flow filtration module, through a second cross-flow filtration module to form a fraction that is enriched with milk proteins selected from the group consisting of albumin, immunoglobulins, β-lactoglobulin, and α-lactalbumin, and a fraction that is depleted of said milk proteins; capturing the fraction that is enriched with milk proteins selected from the group consisting of albumin, immunoglobulins, β-lactoglobulin, and α-lactalbumin; flowing the fraction that is depleted of said milk proteins through a third cross-flow filtration module to form a sialyllactose-enriched fraction and a sialyllactose-depleted fraction; capturing the sialyllactose-enriched fraction; and discharging the sialyllactose-depleted fraction. 44. A method according to claim 1, wherein immunoglobulins are isolated and purified from the milk, said method comprising the steps of:optionally flowing the milk from the milk source through a first cross-flow filtration module to filter out at least a portion of bacteria contained therein; flowing the milk, optionally filtered in the first cross-flow filtration module, through a second cross-flow filtration module to separate the milk into a casein-rich fraction and a casein-depleted fraction; capturing the casein-rich fraction; flowing the casein-depleted fraction of the milk through a third cross-flow filtration module to form an immunoglobulin-rich fraction and an immunoglobulin-depleted fraction; and capturing both the immunoglobulin-rich fraction and the immunoglobulin-depleted fraction. 45. A method according to claim 44 further comprising the additional step of concentrating and/or diafiltering the immunoglobulin-rich fraction.46. A method according to any one of claims 44 and 45 further comprising the additional step of purifying immunoglobulins from the immunoglobulin-rich fraction by a method selected from the group consisting of chromatography, cross-flow filtration, cross-flow chromatography, and diafiltration.47. A method according to any one of claims 44, 45 and 46 further comprising the additional step of concentrating and/or diafiltering the immunoglobulin depleted fraction for further uses.48. A method according to any one of claims 44, 45, 46 and 47 wherein the immunoglobulins have therapeutic effects.49. A method according to any one of claims 44, 45, 46 and 47 wherein the immunoglobulins are used to treat gastrointestinal track disorder.50. A method according to any one of claims 44, 45, 46 and 47 wherein the immunoglobulins are used to treat a mammal of the same species as that of the milk source.51. A method according to any one of claims 44, 45, 46 and 47 wherein the immunoglobulins are used to treat a mammal of a different species from that of the milk source.52. A method according to claim 1, wherein the milk source supplies fluid containing mixtures of complex carbohydrates and lactose, and wherein complex carbohydrates are isolated and purified from said mixtures, said method comprising the steps of:flowing the fluid mixtures from the milk source through a first cross-flow filtration module to separate said mixtures into a complex carbohydrates rich fraction and a complex carbohydrate depleted fraction; capturing both the complex carbohydrates rich fraction and the complex carbohydrates depleted fraction; concentrating and/or diafiltering the complex carbohydrates rich fraction to obtain complex carbohydrates; crystalizing and/or drying the complex carbohydrates; and concentrating and/or diafiltering the complex carbohydrates depleted fraction to obtain lactose; and crystalizing and/or drying the lactose. 53. A method according to claim 1, wherein sialyllactose is isolated from the milk, said method comprising the steps of:flowing the milk from the milk source through a first cross-flow filtration module to separate the milk into a casein-rich fraction and a casein-depleted fraction; capturing the casein-rich fraction; flowing the casein-depleted fraction of the milk through a second cross-flow filtration module to form a fraction that is enriched with milk proteins selected from the group consisting of albumin, immunoglobulins, β-lactoglobulin, and α-lactalbumin, and a fraction that is depleted of said milk proteins; capturing the fraction that is enriched with milk proteins selected from the group consisting of albumin, immunoglobulins, β-lactoglobulin, and α-lactalbumin; flowing the fraction that is depleted of said milk proteins through a third cross-flow filtration module to form a sialyllactose-enriched fraction and a sialyllactose-depleted fraction; capturing the sialyllactose-enriched fraction; and discharging the sialyllactose-depleted fraction. 54. A method according to claim 1, wherein the milk source directly supplies casein-depleted whey, and wherein sialyllactose is separated from said casein-depleted whey, comprising the steps of:flowing the casein-depleted whey from the milk source through a first cross-flow filtration module to form a fraction that is enriched with milk proteins selected from the group consisting of albumin, immunoglobulins, β-lactoglobulin, and α-lactalbumin, and a fraction that is depleted of said milk proteins; capturing the fraction that is enriched with milk proteins selected from the group consisting of albumin, immunoglobulins, β-lactoglobulin, and α-lactalbumin in; flowing the fraction that is depleted of said milk proteins through a second cross-flow filtration module to form a sialyllactose-enriched fraction and a sialyllactose-depleted fraction; capturing the sialyllactose-enriched fraction; and discharging the sialyllactose-depleted fraction. 55. A method according to claim 1, wherein immunoglobulins are isolated and purified from the milk, said method comprising the steps of:flowing the milk from the milk source through a first cross-flow filtration module to separate the milk into a casein-rich fraction and a casein-depleted fraction; capturing the casein-rich fraction; flowing the casein-depleted fraction of the milk through a second cross-flow filtration module to form an immunoglobulin-rich fraction and an immunoglobulin-depleted fraction; capturing both the immunoglobulin-rich fraction and the immunoglobulin-depleted fraction. 56. A method according to claim 55 further comprising the additional step of concentrating and/or diafiltering the immunoglobulin-rich fraction.57. A method according to any one of claims 55 and 56 further comprising the additional step of purifying immunoglobulins from the immunoglobulin-rich fraction by a method selected from the group consisting of chromatography, cross-flow filtration, cross-flow chromatography, and diafiltration.58. A method according to claim 55 further comprising the additional step of concentrating and/or diafiltering the immunoglobulin depleted fraction for further uses.